scispace - formally typeset
S

Stéphanie Vinot

Researcher at Centre national de la recherche scientifique

Publications -  7
Citations -  295

Stéphanie Vinot is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Pronucleus & Cancer. The author has an hindex of 4, co-authored 7 publications receiving 278 citations.

Papers
More filters
Journal ArticleDOI

ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.

TL;DR: Findings indicate that ZNF217 mRNA expression may represent a novel prognostic biomarker in breast cancer and therapeutic targeting of Z NF217 of the TGF-β signaling pathway may benefit the subset of patients whose tumors express high levels of ZNF 217.
Journal ArticleDOI

Two PAR6 Proteins Become Asymmetrically Localized during Establishment of Polarity in Mouse Oocytes

TL;DR: It is shown that two PAR6-related proteins have distinct polarized distributions in mouse oocytes and that mPARD6a is the first identified protein to associate with the spindle during spindle migration and to relocalize to the chromosomes in the absence of microtubule behavior, suggesting a role in spindle Migration.
Journal ArticleDOI

Mitotic spindles and cleavage planes are oriented randomly in the two-cell mouse embryo.

TL;DR: The cleavage pattern of two-cell embryos is studied by videomicroscopy to distinguish between the two hypotheses and argues against a prepatterning of the mouse embryo before compaction.
Book ChapterDOI

Analysis of cell migration and its regulation by Rho GTPases and p53 in a three-dimensional environment.

TL;DR: This chapter provides protocols to assay the ability of cells to migrate or to invade a 3D matrix and to analyze their phenotypes, and describes a method to examine the localization of different markers during 3D migration.
Patent

Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta

TL;DR: In this article, a method of testing a subject thought to be predisposed to having a metastatic cancer which comprises the step of i) analyzing a biological sample from said subject for detecting the presence of a p53 isoform selected in the group consisting in Δ133p53, Δ 133p53γ and Δ139p53β.